Owner Janssen Pharmaceutica NV

Inventors Meerpoel, Lieven; Backx, Leo Jacobus Jozef; Busscher, Guuske Frederike; Ten Holte, Peter

Agent Shelston IP

Pub. Number AU-B-2007310927

PCT Pub. Number WO2008/049808

Priority 06122820.1 24.10.06 EP

Filing date 22 October 2007

Wipo publication date 2 May 2008

Acceptance publication date 12 January 2012

C07C 235/52 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/216 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

C07C 231/02 (2006.01) Preparation of carboxylic acid amides

C07C 231/16 (2006.01) Preparation of carboxylic acid amides

C07C 233/57 (2006.01) Carboxylic acid amides

C07C 233/78 (2006.01) Carboxylic acid amides

C07C 235/54 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 235/60 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07D 207/14 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 223/12 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms